A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study

Abstract Background To evaluate the efficacy and tolerability of a poly-herbal formulation, Herbagut, for the treatment of gastrointestinal symptoms and its effect on quality of life parameters in patients presenting with self-reported, unsatisfactory bowel habits. Methods This was a randomised, dou...

Full description

Bibliographic Details
Main Authors: Adrian L. Lopresti, Hemant Gupta, Stephen J. Smith
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-018-2168-y
_version_ 1819226465231699968
author Adrian L. Lopresti
Hemant Gupta
Stephen J. Smith
author_facet Adrian L. Lopresti
Hemant Gupta
Stephen J. Smith
author_sort Adrian L. Lopresti
collection DOAJ
description Abstract Background To evaluate the efficacy and tolerability of a poly-herbal formulation, Herbagut, for the treatment of gastrointestinal symptoms and its effect on quality of life parameters in patients presenting with self-reported, unsatisfactory bowel habits. Methods This was a randomised, double-blind, placebo-controlled trial. Fifty adults with self-reported unsatisfactory bowel habits, primarily characterised by chronic constipation were randomly allocated to take Herbagut or a matching placebo for 28 days. Efficacy of gastrointestinal changes was measured by the completion of a patient daily diary evaluating changes in stool type (Bristol Stool Form Scale), ease of bowel movements, and feeling of complete evacuation; and the Gastrointestinal Symptom Rating Scale (GSRS). Changes in quality of life were also examined using the World Health Organization Quality of Life – abbreviated version (WHOQOL-BREF), and the Patient Assessment of Constipation-Quality of Life (PAC-QOL). Results All participants completed the 28-day trial with no adverse events reported. Compared to the placebo, weekly bowel movements increased over time (p < .001), as did self-reported, normal bowel motions (76% vs 4%; p < .001). Self-reported incomplete evacuation was also lower in the Herbagut group compared to placebo (24% vs 76%; p = <.001). GSRS domain ratings for abdominal pain, constipation, diarrhoea, indigestion, and reflux also decreased significantly in people taking Herbagut compared to placebo (p < .001, for all domains). Moreover, quality of life significantly improved in the Herbagut group compared to placebo as indicated by significantly greater improvement in WHOQOL-BREF domain ratings for overall quality of life, social relations, environmental health, psychological health, and physical health (p < .001, for all domains); and PAC-QOL domain ratings for physical discomfort, psychosocial discomfort, worries and concerns, and life satisfaction (p < .001, for all domains). The changes were considered clinically meaningful as evidenced by their large effect sizes. Conclusion Herbagut ingestion over a 28-day period resulted in improvements in several gastrointestinal symptoms and overall quality of life. Further investigation utilising larger sample sizes and diverse clinical and cultural populations are needed. Trial registration Clinical Trials Registry- India /2016/11/007479. Registered 24 April 2015 (retrospectively registered).
first_indexed 2024-12-23T10:25:55Z
format Article
id doaj.art-308a14cec8864fc5b6827b3161af2148
institution Directory Open Access Journal
issn 1472-6882
language English
last_indexed 2024-12-23T10:25:55Z
publishDate 2018-03-01
publisher BMC
record_format Article
series BMC Complementary and Alternative Medicine
spelling doaj.art-308a14cec8864fc5b6827b3161af21482022-12-21T17:50:34ZengBMCBMC Complementary and Alternative Medicine1472-68822018-03-0118111310.1186/s12906-018-2168-yA poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled studyAdrian L. Lopresti0Hemant Gupta1Stephen J. Smith2School of Psychology and Exercise Science, Murdoch UniversitySamvedna HospitalSouthern Cross UniversityAbstract Background To evaluate the efficacy and tolerability of a poly-herbal formulation, Herbagut, for the treatment of gastrointestinal symptoms and its effect on quality of life parameters in patients presenting with self-reported, unsatisfactory bowel habits. Methods This was a randomised, double-blind, placebo-controlled trial. Fifty adults with self-reported unsatisfactory bowel habits, primarily characterised by chronic constipation were randomly allocated to take Herbagut or a matching placebo for 28 days. Efficacy of gastrointestinal changes was measured by the completion of a patient daily diary evaluating changes in stool type (Bristol Stool Form Scale), ease of bowel movements, and feeling of complete evacuation; and the Gastrointestinal Symptom Rating Scale (GSRS). Changes in quality of life were also examined using the World Health Organization Quality of Life – abbreviated version (WHOQOL-BREF), and the Patient Assessment of Constipation-Quality of Life (PAC-QOL). Results All participants completed the 28-day trial with no adverse events reported. Compared to the placebo, weekly bowel movements increased over time (p < .001), as did self-reported, normal bowel motions (76% vs 4%; p < .001). Self-reported incomplete evacuation was also lower in the Herbagut group compared to placebo (24% vs 76%; p = <.001). GSRS domain ratings for abdominal pain, constipation, diarrhoea, indigestion, and reflux also decreased significantly in people taking Herbagut compared to placebo (p < .001, for all domains). Moreover, quality of life significantly improved in the Herbagut group compared to placebo as indicated by significantly greater improvement in WHOQOL-BREF domain ratings for overall quality of life, social relations, environmental health, psychological health, and physical health (p < .001, for all domains); and PAC-QOL domain ratings for physical discomfort, psychosocial discomfort, worries and concerns, and life satisfaction (p < .001, for all domains). The changes were considered clinically meaningful as evidenced by their large effect sizes. Conclusion Herbagut ingestion over a 28-day period resulted in improvements in several gastrointestinal symptoms and overall quality of life. Further investigation utilising larger sample sizes and diverse clinical and cultural populations are needed. Trial registration Clinical Trials Registry- India /2016/11/007479. Registered 24 April 2015 (retrospectively registered).http://link.springer.com/article/10.1186/s12906-018-2168-yGastrointestinal functionDigestionHerbal treatmentConstipationClinical trial
spellingShingle Adrian L. Lopresti
Hemant Gupta
Stephen J. Smith
A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
BMC Complementary and Alternative Medicine
Gastrointestinal function
Digestion
Herbal treatment
Constipation
Clinical trial
title A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
title_full A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
title_fullStr A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
title_full_unstemmed A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
title_short A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study
title_sort poly herbal blend herbagut r on adults presenting with gastrointestinal complaints a randomised double blind placebo controlled study
topic Gastrointestinal function
Digestion
Herbal treatment
Constipation
Clinical trial
url http://link.springer.com/article/10.1186/s12906-018-2168-y
work_keys_str_mv AT adrianllopresti apolyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy
AT hemantgupta apolyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy
AT stephenjsmith apolyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy
AT adrianllopresti polyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy
AT hemantgupta polyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy
AT stephenjsmith polyherbalblendherbagutonadultspresentingwithgastrointestinalcomplaintsarandomiseddoubleblindplacebocontrolledstudy